Year Published
- 2008 (4) Apply 2008 filter
- 2009 (19) Apply 2009 filter
- 2010 (24) Apply 2010 filter
- 2011 (11) Apply 2011 filter
- 2012 (18) Apply 2012 filter
- 2013 (7) Apply 2013 filter
- 2014 (5) Apply 2014 filter
- 2015 (7) Apply 2015 filter
- 2016 (8) Apply 2016 filter
- (-) Remove 2017 filter 2017
- 2018 (1) Apply 2018 filter
- (-) Remove 2019 filter 2019
- 2020 (1) Apply 2020 filter
- 2021 (2) Apply 2021 filter
Research Topics
Populations
Types of Research
Geography
- East Africa Region and Selected Countries (4) Apply East Africa Region and Selected Countries filter
- Global (5) Apply Global filter
- South Asia Region and Selected Countries (3) Apply South Asia Region and Selected Countries filter
- Southern Africa Region and Selected Countries (1) Apply Southern Africa Region and Selected Countries filter
- Sub-Saharan Africa (2) Apply Sub-Saharan Africa filter
- West Africa Region and Selected Countries (2) Apply West Africa Region and Selected Countries filter
Dataset
Current search
- (-) Remove Global & Regional Public Goods filter Global & Regional Public Goods
- (-) Remove Household Well-Being & Equity filter Household Well-Being & Equity
- (-) Remove Aid & Other Development Finance filter Aid & Other Development Finance
- (-) Remove 2017 filter 2017
- (-) Remove Market & Value Chain Analysis filter Market & Value Chain Analysis
- (-) Remove 2019 filter 2019
- (-) Remove Food Security & Nutrition filter Food Security & Nutrition
EPAR Technical Report #338
Publication Date: 05/19/2017
Type: Literature Review
Abstract
The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly (non-rival consumption) and it is difficult or costly to exclude non-payers from gaining access (non-excludable). This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources.